Browsing by Author BECK R.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Publication YearJRC N°TitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2011JRC65531177Lu-immunotherapy of experimental peritoneal carcinomatosis shows comparable effectiveness to 213Bi-immunotherapy, but causes toxicity not observed with 213BiSEIDL C.; ZÖCKLER C; BECK R.; QUINTANILLA-MARTINEZ L; BRUCHERTSEIFER Frank; SENEKOWITSCH-SCHMIDTKE R.Articles in Journals
2007JRC41950213Bi-radioimmunotherapy Defeats Early-stage Disseminated Gastric Cancer in Nude MiceBECK R.; SEIDL C.; PFOST B.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; BAUM M.; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Articles in Journals
2005JRC30040Cell Death Triggered by Alpha-emitting 213Bi-immunoconjugates in HSC45-M2 Gastric Cancer Cells is different from Apoptotic Cell Death.SEIDL C.; SCHROECK H.; SEIDENSCHWANG S.; BECK R.; SCHMID E.; ABEND M.; BECKER K.-F.; APOSTOLIDIS CHRISTOS; NIKULA Tuomo; KREMMER E., et alArticles in Journals
2005JRC30250Fractionated Locoregional Low-Dose Radioimmunotherapy Improves Survival in a Mouse Model of Diffuse Type Gastric Cancer Using A 213BI-conjugated Monoclonal AntibodyBLOECHEL S.; BECK R.; SEIDL C.; MORGENSTERN ALFRED; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Articles in Journals
2007JRC38135Non-invasive Visualisation of the Development of Peritoneal Carcinomatosis and Tumour Regression After 213Bi-radioimmunotherapy Using Bioluminescence ImagingBUCHHORN H.m.; SEIDL C.; BECK R.; SAUR D.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Articles in Journals